Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
Judith E Karp1, Jeffrey E Lancet21Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA; 2H. Lee Moffitt Comprehensive Cancer Center, Tampa, Florida, USAAbstract: Farnesyltransferase inhibitors (FTIs) represent a new class of signal t...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-09-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/tipifarnib-in-the-treatment-of-newly-diagnosed-acute-myelogenous-leuke-a2298 |